Long-term health consequences of PCOS
- PMID: 12078834
- DOI: 10.1093/humupd/8.3.231
Long-term health consequences of PCOS
Abstract
The prevalence of cardiovascular risk factors, insulin resistance/diabetes and/or uterine pathology appears to be increased in women with polycystic ovarian syndrome (PCOS), although more outcome studies are necessary to determine incidence. Data pertaining to some of the potential long-term health consequences associated with PCOS are summarized. Medline, Current Contents and PubMed were searched for studies from the time of our original interest in this issue in 1980 to the present. The review is limited to published human data. The current literature indicate that women with this syndrome cluster risk factors for premature morbidity and mortality. Large multi-site co-operative studies are necessary to evaluate the long-term health outcomes.
Similar articles
-
Type 2 diabetes and the polycystic ovary syndrome.Minerva Ginecol. 2004 Feb;56(1):41-51. Minerva Ginecol. 2004. PMID: 14973409 Review.
-
Metabolic consequences of polycystic ovary syndrome.Minerva Ginecol. 2015 Dec;67(6):545-55. Epub 2015 Sep 15. Minerva Ginecol. 2015. PMID: 26372304 Review.
-
Polycystic ovary syndrome and the postmenopausal woman.J Br Menopause Soc. 2006 Dec;12(4):143-8. doi: 10.1258/136218006779160580. J Br Menopause Soc. 2006. PMID: 17178014 Review.
-
Polycystic ovarian syndrome (PCOS): Long-term metabolic consequences.Metabolism. 2018 Sep;86:33-43. doi: 10.1016/j.metabol.2017.09.016. Epub 2017 Oct 10. Metabolism. 2018. PMID: 29024702 Review.
-
Comorbidities in polycystic ovary syndrome: their relationship to insulin resistance.Panminerva Med. 2008 Dec;50(4):295-304. Panminerva Med. 2008. PMID: 19078870 Review.
Cited by
-
The gut microbiota: emerging biomarkers and potential treatments for infertility-related diseases.Front Cell Infect Microbiol. 2024 Sep 26;14:1450310. doi: 10.3389/fcimb.2024.1450310. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 39391885 Free PMC article. Review.
-
Clinical efficacy and metabolic impact of two different dosages of ethinyl-estradiol in association with drospirenone in normal-weight women with polycystic ovary syndrome: a randomized study.J Endocrinol Invest. 2013 Sep;36(8):636-41. doi: 10.1007/BF03346756. J Endocrinol Invest. 2013. PMID: 24105072 Clinical Trial.
-
The Cut-Off Value for the Triglyceride-Glucose Index (TyG) Discriminating Insulin Resistance Based on the SHBG Level and HOMA-IR Values in Women with Polycystic Ovary Syndrome.Life (Basel). 2025 Apr 23;15(5):691. doi: 10.3390/life15050691. Life (Basel). 2025. PMID: 40430120 Free PMC article.
-
Overlap of proteomics biomarkers between women with pre-eclampsia and PCOS: a systematic review and biomarker database integration.Hum Reprod. 2015 Jan;30(1):133-48. doi: 10.1093/humrep/deu268. Epub 2014 Oct 28. Hum Reprod. 2015. PMID: 25351721 Free PMC article.
-
Polycystic ovary syndrome: etiology, pathogenesis and diagnosis.Nat Rev Endocrinol. 2011 Apr;7(4):219-31. doi: 10.1038/nrendo.2010.217. Epub 2011 Jan 25. Nat Rev Endocrinol. 2011. PMID: 21263450 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical